Case-Based Roundtable
General Dermatology
Eczema
Chronic Hand Eczema
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management
Prurigo Nodularis
Buy-and-Bill

Article

May 1, 2004

How can sentinel node biopsy, isolated limb chemotherapy treat regional, recurrent melanoma?

New York - The sentinel node biopsy was first introduced by Donald Morton, M.D., from the John Wayne Cancer Institute in 1992 as an attractive alternative to a complete lymph node dissection. One objective of sentinel node biopsy has been to reduce the morbidity associated with an elective lymph node dissection without sacrificing accurate pathological examination. However, it has also been suggested that sentinel node biopsy might improve patient outcome.

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!